menu ☰
menu ˟

Exclusive: ICGP CEO resigns to join RCSI

11 May 2016

ICGP CEO Kieran Ryan has resigned from the College to take up the post of Managing Director of Surgical Affairs at the RCSI.

Ryan, who joined the ICGP in 2011 to replace the retiring Fionán Ó Cuinneagáin, will replace Eunan Friel in the RCSI’s Senior Management Team this summer, and will be responsible for delivering the vision of the Department of Surgical Affairs, as well as the 2016-2020 Surgical Strategy that supports it.

Prior to taking over as Chief Executive in Lincoln Place, Ryan was associate director and surgical research and development manager at the RCSI, with responsibility for the oversight of surgical training programmes, professional competence development and surgical research programmes.

He leaves the ICGP at a critical juncture in the College’s development, as the agreement to transfer the oversight and delivery of GP training from the HSE to the College nears completion. Heads of agreement between the two parties are expected shortly, after which the Executive will go to the Department of Public Expenditure and Reform to seek clarity on how the transfer will happen in terms of redundancies, retirements or transfers of the existing programme director and assistant programme director posts currently employed by the HSE.

As reported last week in IMT, a figure of approximately €8 million has been suggested as the ‘funding envelope’ agreed for a national GP training scheme.

The College has reported an operational deficit of €419,184 for 2015, compared to a surplus of €115,600 the previous year. The significant deficit was as a result of a decrease in income of €226,431, an increase in operating expenditure of €328,688 and an increase in net finance income of €20,335.

On the income side, membership subscriptions and levy have been reduced by €73,756 and sponsorship by €31,476. The reduction in income from Professional Competence of €116,155, however, was described in the College’s Annual Report as a “timing issue”, and while this income would be received in the first four months of 2016, it adversely affected the 2015 results and would give a once-off improvement to 2016.

Education and eLearning also required significant additional subvention by the College to the tune of €98,000 last year. However, overall projections show finances should bounce back to break even by the end of the year, and the College’s balance sheet shows healthy reserves of €3,197,603 and net current assets of €1,601,301.

Ryan’s resignation as CEO comes on foot of several other, unrelated high-profile departures, the biggest of which is Dr Margaret O’Riordan, who has stepped down as Medical Director after 18 years with the College.

Replacements for outgoing Chairperson Dr Mary Sheehan and departing Chair of the College’s Postgraduate Training Committee Dr Karena Hanley, whose terms of office have ended, have yet to be chosen by the new Board. Meanwhile, Dr Gerry Mansfield is also leaving his role as National Director of Training to focus more on his practice.

“It is going to be a challenge, but this is what an organisation like the ICGP is all about — it’s about renewal, revitalising things, and I think we can maintain continuity if the people involved are experienced,” Ryan recently told IMT, when commenting on those other departures. “But [if they leave] we also get people with new ideas and approaches, and that keeps the innovation in the College alive.”

The College has held interviews for Dr O’Riordan’s replacement and is understood to be close to making an appointment.

At the RCSI, Ryan will also be responsible for supporting the development of the RCSI’s global Fellowship, international surgical initiatives and critical professional programmes in Ireland.

The Surgical Affairs Department is responsible for the delivery of excellence in postgraduate surgical training and examinations as well as supporting clinical excellence in surgical practice in Ireland, according to the College.

Prior to the RCSI, Ryan was director of clinical services at Hermitage Medical Clinic, an executive with the Irish Health Services Accreditation Board, an inspector with the Irish Medicines Board and a clinical trials manager with GlaxoSmithKline Ireland.

By Dara Gantly & Lloyd Mudiwa,


Click here to view the full article which appeared in Irish Medical Times